Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

UK researchers say lateral flow tests detect the most infectious COVID cases

Published 21/01/2021, 00:03
Updated 21/01/2021, 00:05

LONDON (Reuters) - Rapid lateral flow tests will likely identify the most infectious COVID-19 cases with higher viral loads despite concerns over the overall sensitivity of the tests, Oxford University researchers said on Thursday, as the British government eyes mass testing to ease the current lockdown.

Along with the roll-out of COVID-19 vaccines, the government has cited widespread testing, including lateral flow tests, as a key part of its plans to re-open the economy. Concerns about the tests' accuracy have led some to question the plan, however.

Some scientists have sounded alarm at Prime Minister Boris Johnson's plans, dubbed "Operation Moonshot", saying mass coronavirus testing is likely to be ineffective and expensive.

Lateral flow tests are less sensitive than PCR tests, which are considered the gold standard, but can return results in just half an hour. Lateral flow tests work best among those with higher viral loads - more virus detected in the nose and throat.

Looking at data from more than a quarter of a million people who have taken part in England's test and trace scheme, scientists found that the greater the viral load, the more infectious the person.

Applying previous estimates of the sensitivity of four lateral flow devices to those findings, the researchers found that the tests would detect between 83.7% and 90.5% of cases leading to onward transmission.

"We know that lateral flow tests are not perfect, but that doesn't stop them being a game changer for helping to detect large numbers of infectious cases sufficiently rapidly to prevent further onward spread," said Tim Peto, Professor of Medicine at the University of Oxford.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The researchers said they could not ascertain most of those who had been infected asymptomatically, however, "which may contribute substantially to onward transmission."

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.